This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Georgia trails other states in home health ratings Patient of Conyers Healthcare company says billing issues are affecting her health Piedmont Atlanta taps new chief medical officer SCA Health ASC to close, relocate operations Summit Spine opens 1st South Carolina practice Top 10 Georgia health stories for 2015 Wellstar MCG helps bridge gap in Ga.
Even seemingly popular plan ideas like prescriptiondrugpricing and coverage for pre-existing conditions can’t get traction in Congress or through the White House’s executive pen.
The authors note that “consumer-driven” health care is, “associated with neoliberal efforts to emphasize market factors in health reform,” de-emphasizing government regulation and financing. This concept can be potentially harmful, they believe, assuming that health care is a traditional market.
consumers have been supportive of government negotiation for drugpricing since well before the COVID-19 pandemic. The Gallup-West Health Poll finds similar massive support for government negotiation specifically for COVID-19 treatment pricing, shown in the third table. bn to $32.8 bn to $9.9 bn for Medicaid.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content